https://www.selleckchem.com/products/vb124.html
3% on the membrane after filtration with 108 CFU mL-1 Escherichia coli and Staphylococcus aureus solution as feed, respectively. The coating layer and assembled nanocapsules endowed the membrane with improved lysozyme stability, anti-adhesion performance, and antibacterial activity. Stimuli-responsive lysozyme nanocapsule engineered microfiltration membranes show great potential for anti-biofouling in future practical application.Cancer is a dynamic disease with heterogenic molecular signatures and constantly evolves during the course of
Like
Comment
Share
